Author: digi

Challenges in Global Site Feasibility Assessments for Clinical Trials

June 11, 2025

Overcoming Challenges in Global Site Feasibility Assessments Global site feasibility assessments are essential for selecting suitable clinical trial sites across diverse geographical regions. However, expanding feasibility efforts internationally introduces significant complexities. Sponsors and CROs must navigate regulatory differences, operational hurdles, and cultural nuances while ensuring consistent, quality-driven site selection. This tutorial explores the key challenges…

Site Feasibility Assessments, Site Management and Monitoring

Leveraging Social Media to Boost Patient Recruitment

June 11, 2025

digi

Leveraging Social Media to Boost Patient Recruitment How to Use Social Media to Enhance Patient Recruitment in Clinical Trials Patient recruitment remains one of the biggest hurdles in clinical research. Traditional methods like site outreach, posters, or referral networks often fall short in reaching eligible, diverse patient populations. Social media platforms such as Facebook, Instagram,…

Patient Recruitment and Retention, Recruitment Strategies

Key Advantages of Partnering with Full-Service CROs in Clinical Trials

June 11, 2025

digi

Key Advantages of Partnering with Full-Service CROs in Clinical Trials Exploring the Strategic Benefits of Full-Service CRO Partnerships in Clinical Trials In the evolving landscape of clinical research, pharmaceutical and biotechnology companies are increasingly turning to Contract Research Organizations (CROs) to manage their clinical trials. Among various models, partnering with a full-service CRO offers comprehensive…

Contract Research Organizations (CROs), Full-Service CROs

Fundamentals of the Informed Consent Process in Clinical Trials

June 10, 2025

digi

Fundamentals of the Informed Consent Process in Clinical Trials Understanding the Basics of the Informed Consent Process in Clinical Trials The informed consent process is a cornerstone of ethical conduct in clinical trials. It ensures that participants are adequately informed about a study’s purpose, risks, benefits, and their rights, before voluntarily agreeing to participate. This…

Informed Consent and Ethics Committees, Informed Consent Process

How to Design Effective Site Feasibility Questionnaires for Clinical Trials

June 10, 2025

digi

How to Design Effective Site Feasibility Questionnaires for Clinical Trials Designing Site Feasibility Questionnaires that Drive Successful Clinical Trial Site Selection A well-designed site feasibility questionnaire (SFQ) is essential for evaluating and selecting the right sites for clinical trials. The SFQ allows sponsors and CROs to collect critical operational, regulatory, and clinical information from potential…

Site Feasibility Assessments, Site Management and Monitoring

Using Real-World Evidence (RWE) to Complement Phase 3 Data: Enhancing Clinical Trial Outcomes and Regulatory Value

June 10, 2025

digi

Using Real-World Evidence (RWE) to Complement Phase 3 Data: Enhancing Clinical Trial Outcomes and Regulatory Value How Real-World Evidence Can Strengthen Phase 3 Clinical Trial Programs Why Real-World Evidence Matters in the Phase 3 Context Phase 3 clinical trials provide controlled and statistically powered evidence on a drug’s safety and efficacy. However, they are conducted…

Phase 3 (Confirmation and Monitoring)

Regulatory Submissions and IRB Coordination in Clinical Trials

June 10, 2025

digi

Effective Coordination of Regulatory Submissions and IRB Approvals One of the most critical components of clinical study start-up is the preparation and coordination of regulatory submissions and Institutional Review Board (IRB) approvals. A smooth regulatory process ensures ethical compliance, protects subjects, and prevents study delays. This tutorial outlines best practices, timelines, and responsibilities in regulatory…

Clinical Research Operations, Study Start-Up Activities

Using Historical Data for Site Ranking in Clinical Trials

June 10, 2025

digi

Leveraging Historical Performance Data for Clinical Trial Site Ranking In modern clinical research, selecting the right sites is one of the most critical determinants of study success. Rather than relying solely on feasibility surveys or investigator CVs, sponsors and CROs now utilize historical data to rank and qualify sites more accurately. This approach leads to…

Site Management and Monitoring, Site Performance Metrics

Wearable Devices for Continuous Data Collection in Decentralized Clinical Trials

June 10, 2025

digi

Wearable Devices for Continuous Data Collection in Decentralized Clinical Trials Using Wearable Devices for Continuous Data Collection in Decentralized Clinical Trials Wearable devices have become a cornerstone of modern GMP compliance in decentralized clinical trials (DCTs). These smart technologies allow for passive, continuous data collection from participants without requiring frequent clinic visits. From heart rate…

Decentralized Clinical Trials (DCTs), Remote Patient Monitoring

Building a Targeted Recruitment Strategy from Site Feasibility

June 10, 2025

digi

Building a Targeted Recruitment Strategy from Site Feasibility How to Build a Targeted Patient Recruitment Strategy from Site Feasibility One of the most common causes of clinical trial delays is the failure to meet patient enrollment targets. A well-executed recruitment strategy, rooted in site feasibility insights, significantly enhances a trial’s success. Sponsors and CROs must…

Patient Recruitment and Retention, Recruitment Strategies